| 4AQC: reference: A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779., Dugan BJ, Gingrich DE, Mesaros EF, Milkiewicz KL, Curry MA, Zulli AL, Dobrzanski P, Serdikoff C, Jan M, Angeles TS, Albom MS, Mason JL, Aimone LD, Meyer SL, Huang Z, Wells-Knecht KJ, Ator MA, Ruggeri BA, Dorsey BD, J Med Chem. 2012 Jun 14;55(11):5243-54. Epub 2012 May 18. PMID: 22594690 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).